NCT06557252

The Application of the PDCA Management Model in Improving the Diagnostic Accuracy of AIG

• Status: Not Yet Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 16 (estimated)
• Sponsor: Ningbo No. 1 Hospital · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Autoimmune gastritis is currently relatively rare in China due to its insidious onset, diverse clinical manifestations involving multiple systems such as digestive, hematological, and nervous systems, and its association with other autoimmune diseases. It can also be complicated by hyperplastic gastric polyps, gastric neuroendocrine tumors, gastric adenocarcinoma, and other diseases, making it prone to clinical misdiagnosis. As a form of gastritis in the post-Helicobacter pylori era, its detection rate has been gradually increasing with the continuous improvement of endoscopic technology in China. Applying the PDCA cycle management in disease diagnosis can significantly improve the detection rate of the disease, benefiting patients. Through the PDCA management model, this study further enhanced gastroenterologists' understanding of this disease from various aspects, aiming to improve the clinical diagnosis of autoimmune gastritis.

Conditions

• Autoimmune Gastritis

Interventions

Type	Name	Description
BEHAVIORAL	PDCA training	Improve diagnostic rate

Timeline

• Start date: 2024-08-15
• Primary completion: 2024-12-31
• Completion: 2024-12-31
• First posted: 2024-08-16
• Last updated: 2024-08-16

Locations

1 site across 1 country: China